bluebird bio, Inc. (BLUE)
Latest BLUE Insider Trades
About bluebird bio, Inc. (BLUE)
bluebird bio, Inc. files with the SEC under CIK 0001293971 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
90-Day SEC Filing Activity
No Form 4 activity for BLUE in the last 90 days.
BLUE Insider Transactions (Form 4)
5827 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew Obenshain - Officer | Other | Common Stock | 9,027 |
BLUE Insider Trading - FAQ
What is the latest insider trade for BLUE?
bluebird bio, Inc. (BLUE) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-06-03. The full record for BLUE runs to 27 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BLUE stock?
No insider purchases of BLUE were filed in the last 90 days.
How many insiders are selling BLUE stock?
No insider sales of BLUE were filed in the last 90 days. 4 sales are on record for this company.
Where can I see BLUE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks BLUE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BLUE insider buys?
Create a free InsiderAlpha account and press Watch on this page to add BLUE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Andrew Obenshain view on EDGAR
- - Nick Leschly view on EDGAR
- - Thomas J. Klima view on EDGAR
- - Elisabeth Leiderman view on EDGAR
- - Mark Vachon view on EDGAR
- - John O. Agwunobi view on EDGAR
- - Charlotte Jones-Burton view on EDGAR
- - Richard A. Colvin view on EDGAR
- - Joseph Vittiglio view on EDGAR
- - Najoh Tita-Reid view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where BLUE's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track BLUE insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
